1

BUKU PANDUAN MAHASISWA

BLOK MEDICAL RESEARCH PROGRAM (5.2)

Disusun oleh :
Dr. dr. Lantip Rujito, M.Si. Med.
dr. Afifah, M.Sc.
dr. Khusnul Muflikhah, M.Sc.

KEMENTERIAN RIET, TEKNOLOGI DAN PENDIDIKAN TINGGI

UNIVERSITAS JENDERAL SOEDIRMAN
FAKULTAS KEDOKTERAN
JURUSAN KEDOKTERAN UMUM
2018
 2

DESKRIPSI BLOK
Blok Medical Research Program (5.2) merupakan blok kedua dalam semester lima. Pada blok
ini mahasiswa mempelajari metodologi penelitian kedokteran. Blok ini memiliki beban 4 SKS.

KARAKTERISTIK MAHASISWA
Mahasiswa yang mengikuti Blok Medical Research Program adalah mahasiswa semester lima.

KONTRIBUTOR
Kontributor Blok Medical Research Program adalah bagian:
o Komisi Ilmiah
o Bioetik
o IKM

TUJUAN UMUM
Pada akhir blok, mahasiswa diharapkan mampu :
- Menyusun sebuah proposal penelitian kedokteran
- Mengidentifikasi adanya permasalahan etik pada sebuah penelitian kedokteran
- Melakukan analisis statistik pada data hasil penelitian kedokteran
- Menyusun sebuah laporan dan artikel penelitian kedokteran
- Melakukan critical appraisal pada sebuah jurnal/berkala kedokteran

ORGANISASI PENGELOLA BLOK

1. PIC 1 : Dr. dr. Lantip Rujito, M.Si, Med
2. PIC 2 : dr. Khusnul Muflikhah, M.Sc
3. Administrasi : Meike Wihastuti, SE.
 3

JADWAL GLOBAL PROSES PEMBELAJARAN DAN TANGGAL PENTING

TEMA/TOPIK WAKTU
Kuliah 24 September-14 Oktober 2018
Tutorial Tutorial 1 Kamis, 27 September 2018 Pkl.10.00-11.40
Tutorial 2 Selasa, 2 Oktober 2018 Pkl.10.00-11.40
Tutorial 3 Kamis, 4 Oktober 2018 Pkl.10.00-11.40
Tutorial 4 Selasa, 9 Oktober 2018 Pkl.10.00-11.40
Tutorial 5 Kamis, 11 Oktober 2018, Pkl.10.00-11.40
Praktikum Pengolahan Data Praktikum I Gelombang I : Jum’at,12 Oktober 2018,
pkl.13.00-14.40
Gelombang II : Senin, 15 Oktober 2018,
pkl.08.00-09.40
Praktikum II Senin, 15 Oktober 2018, pkl.10.00-11.40
Selasa, 16 Oktober 2018, pkl.08.00-09.40
Praktikum Etika Penelitian Jum’at, 12 Oktober 2018, pkl. 10.00-11.40
Praktikum Critical Appraisal Praktikum I Senin, 15 Oktober 2018, pkl.10.00-11.40
Praktikum II Selasa, 15 Oktober 2018, pkl. 10.00-11.40
CBT CBT 1 : Senin, 8 Oktober 2018
CBT 2 : Rabu, 17 oktober 2018
Presentasi Proposal Kamis, 18 Oktober 2018
Remidi CBT Jum’at, 19 Oktober 2018

MATRIKS KURIKULUM
No Topik Tujuan Pembelajaran Pengampu Metode Durasi
1 Hipotesis Penelitian 1. Mahasiswa mampu dr. Yudhi Kuliah 50
menjelaskan pengertian Wibowo, M.PH
hipotesis
2. Mahasiswa mampu menjelaskan
cirri hipotesis yang baik
3. Mahasiswa mampu menjelaskan
jenis-jenis hipotesis
2 Populasi dan Sampel 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
pengertian dan karakteristik Wibowo, M.PH
populasi
 4

2. Mahasiswa mampu menjelaskan

konsep sampel sebagai bagian
representatif dari populasi
3 Variabel dan Skala 1. Mahasiswa mampu menjelaskan Dr.dr. Lantip Kuliah 100
Penelitian pengertian dan jenis-jenis Rujito,
variabel M.Si.Med
2. Mahasiswa mampu menjelaskan
hubungan antar variabel
3. Mahasiswa mampu menjelaskan
definisi operasional variable
4. Mahasiswa mampu menjelaskan
jenis-jenis skala penelitian
beserta ciri-cirinya
4 Pengukuran Data dan 1. Mahasiswa mampu menjelaskan Dr.dr. Nendyah Kuliah 100
Instrumen Penelitian metode pengukuran data Roestijawati,
2. Mahasiswa mampu menjelaskan MKK
metode pengumpulan data
untuk kepentingan penelitian
3. Mahasiswa mampu menjelaskan
pemilihan instrumen penelitian
4. Mahasiswa mampu menjelaskan
prinsip penyusunan instrumen
penelitian
5. Mahasiswa mampu menjelaskan
uji validitas dan reliabilitas pada
instrument penelitian
5 Dasar-dasar 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
Biostatistika konsep dasar statistika Wibowo, M.PH
2. Mahasiswa mampu menjelaskan
manfaat biostatistika dalam
penelitian
3. Mahasiswa mampu penjelaskan
peran probabilitas dalam data
penelitian kesehatan
6 Statistik Deskriptif 1. Mahasiswa mampu menjelaskan Dr.dr. Nendyah Kuliah 100
berbagai teknik penyajian data Roestijawati,
baik data kualitatif maupun data MKK
kuantitatif
2. Mahasiswa mampu menjelaskan
penggunaan statistik untuk
mendeskripsikan atribut suatu
kumpulan data dan menyusun
distribusi frekuensi
3. Mahasiswa mampu menghitung
ukuran kecenderungan sentral
(central tendency ratio) untuk
mendeskripsikan titik tengah
distribusi suatu pengukuran,
yaitu mean, median, dan modus
4. Mahasiswa mampu membuat
dan mendeskripsikan ukuran
penyebaran dan ukuran
pemusatan dalam bentuk tabel
 5

dan grafik untuk variabel

numeric

7 Sampling dan 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100

Estimasi berbagai teknik sampling Wibowo, M.PH
2. Mahasiswa mampu menjelaskan
perhitungan jumlah sampel
yang diperlukan pada populasi
3. Mahasiswa mampu menjelaskan
konsep convidence interval dan
interpretasinya
4. Mahasiswa mampu menjelaskan
perhitungan jumlah sampel
pada proporsi dan populasi
8 Rancangan Penelitian 1. Mahasiswa mampu menjelaskan dr. Miko Kuliah 100
Kualitatif definisi penelitian kualitatif Ferine,
2. Mahasiswa mampu menjelaskan M.Med.Ed
metodologi penelitian kualitatif
9 Instrumen penelitian 1. Mahasiswa mampu menjelaskan RR.Dyah Woro, Kuliah 50
kualitatif mengenai instrument penelitian M.A
kualitatif
10 Pengolahan dan 1. Mahasiswa mampu menjelaskan RR.Dyah Woro, Kuliah 100
Penyajian Data proses pengolahan dan M.A
Kualitatif penyajian data pada penelitian
kualitatif
11 Rancangan Penelitian 1. Mahasiswa mampu menjelaskan Dr.dr. Eman Kuliah 100
Kuantitatif definisi penelitian kuantitatif Sutrisna.,
2. Mahasiswa mampu menjelaskan M.Kes
jenis-jenis penelitian kuantitatif
beserta cirinya
12 Penelitian 1. Mahasiswa mampu menjelaskan Dr.dr. Nendyah Kuliah 100
Epidemiologi definisi penelitian epidemiologi Roestijawati,
Observasional observasional MKK
2. Mahasiswa mampu menjelaskan
jenis-jenis penelitian
epidemiologi observasional
3. Mahasiswa mampu menjelaskan
penggunaan penelitian
epidemiologi observasional
13 Rancangan Penelitian 1. Mahasiswa mampu menjelaskan Dr.dr.Dody Kuliah 100
Eksperimental definisi penelitian Novrial, SpPA.,
Laboratoris eksperimental laboratoris M.Si.Med
2. Mahasiswa mampu menjelaskan
penelitian dengan hewan coba
3. Mahasiswa mampu menjelaskan
teknik handling hewan coba
yang benar
4. Mahasiswa mampu menjelaskan
penelitian in vitro
14 Rancangan Penelitian 1. Mahasiswa mampu menjelaskan Dr.dr. Wahyu Kuliah 100
Eksperimental definisi penelitian eksperimental Siswandari,
Dengan Subyek dengan subyek manusia Sp.PK.,
Manusia M.Si.Med
 6

2. Mahasiswa mampu menjelaskan

penelitian quasi eksperimental
3. Mahasiswa mampu menjelaskan
uji klinis
15 Pengolahan Data 1. Mahasiswa mampu menjelaskan Dr.dr. Lantip Kuliah 100
tahap-tahap pengolahan data Rujito, M.Si.
2. Mahasiswa mampu menjelaskan Med Praktikum 100
cara penyajian data
3. Mahasiswa mampu melakukan
pengolahan data untuk
kepentingan uji statistika
16 Uji Hipotesis 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
definisi uji hipotesis Wibowo, M.PH
2. Mahasiswa mampu menjelaskan
tahap-tahap uji hipotesis
3. Mahasiswa mampu menjelaskan
pemilihan uji statistik
4. Mahasiswa mampu menjelaskan
nilai α (type II error) dan nilai β
(power) dalam uji hipotesis
17 StatisikParametrik 1. Mahasiswa mampu menjelaskan Dr.dr. Nendyah Kuliah 100
dan Non Parametrik definisi statistik parametrik dan Roestijawati,
non parametrik MKK
2. Mahasiswa mampu menjelaskan
perbedaan uji statistik
parametrik dan non parametric
18 Uji Beda Pada 2 1. Mahasiswa mampu menjelaskan dr. Khusnul Kuliah 100
Kelompok pemilihan uji beda antara 2 Muflikhah,
kelompok (uji t, Mann-Whitney, M.Sc
Wilcoxon)
2. Mahasiswa mampu menjelaskan
interpretasi dari uji beda antara
2 kelompok

19 Uji Beda Antara 3 1. Mahasiswa mampu menjelaskan dr. Alfi Kuliah 100
Kelompok atau Lebih pemilihan uji beda antara 3 Muntafiah,
kelompok (ANOVA, ANCOVA, M.Sc
Kruskal-Wallis)
2. Mahasiswa mampu menjelaskan
interpretasi dari uji beda antara
3 kelompok atau lebih
3. Mahasiswa mampu menjelaskan
pemilihan uji post hoc beserta
interpretasinya
20 Analisis 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
Multivariabel dasar pemilihan analisis Wibowo, M.PH
multivariabel
2. Mahasiswa mampu memilih uji
statistik multivariabel yang
tepat (regresi logistik, regresi
linier berganda, korelasi
berganda)
 7

3. Mahasiswa mampu menjelaskan

interpretasi dari uji statistik
multivariable
21 Uji Regresi 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
pemilihan uji regresi (linier Wibowo, M.PH
sederhana, berganda, logistik)
2. Mahasiswa mampu menjelaskan
interpretasi dari uji regresi
22 Uji Korelasi 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
pemilihan uji korelasi (Pearson, Wibowo, M.PH
Spearman, berganda, koefisien
kontingensi)
2. Mahasiswa mampu menjelaskan
interpretasi dari uji korelasi
3. Mahasiswa mampu menjelaskan
kekuatan hubungan
berdasarkan uji korelasi
23 Uji Asosiasi 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
pemilihan uji asosiasi (Chi Wibowo, M.PH
Square, Fisher, McNemar)
2. Mahasiswa mampu menjelaskan
interpretasi interpretasi dari uji
asosiasi
3. Mahasiswa mampu menjelaskan
Odds Ratio dan Relative Risk
24 Analisis Kualitatif 1. Mahasiswa mampu menjelaskan RR.Dyah Woro, Kuliah 100
teknik analisis kualitatif M.A
2. Mahasiswa mampu menjelaskan
kesimpulan / interpretasi teknik
analisis kualitatif
25 Etika Penelitian 1. Mahasiswa mampu menjelaskan dr. Amalia Kuliah 100
konsep dasar etika penelitian Muhaimin,
2. Mahasiswa mampu menjelaskan M.Sc Praktikum 100
regulasi tentang etik penelitian
pada hewan dan manusia
3. Mahasiswa mampu menjelaskan
hal-hal yang potensial menjadi
isu etik dalam penelitian
4. Mahasiswa mampu melakukan
simulasi informed consent
penelitian
26 Teknik Penulisan 1. Mahasiswa mampu menjelaskan dr. Vitasari Kuliah 100
Proposal Penelitian, perbedaan antara penulisan Indriani, Praktikum 500
Laporan Penelitian, usul penelitian dan laporan MM,MSi.Med., Penyusunan
Jurnal Ilmiah, dan penelitian Sp.PK Proposal
Poster Ilmiah 2. Mahasiswa mampu menjelaskan
teknik penulisan laporan
penelitian sesuai kaidah umum
3. Mahasiswa mampu menjelaskan
teknik jurnal dan artikel ilmiah
sesuai kaidah umum
4. Mahasiswa mampu menjelaskan
teknik penyusunan poster ilmiah
 8

27 Telaah Jurnal Ilmiah 1. Mahasiswa mampu menjelaskan Dr.dr. Nendyah Kuliah 100
dan Critical teknik telaah jurnal ilmiah Roestijawati, Praktikum 100
Appraisal 2. Mahasiswa mampu memakai MKK
CONSORT dan STROBE dalam
kritisi jurnal.
3. Mahasiswa mampu
menjelaskan cara melakukan
critical appraisal pada suatu
jurnal ilmiah

METODE PEMBELAJARAN

I. KNOWLEDGE/KOGNITIF
1.A. KULIAH
Kuliah pendahuluan merupakan metode pemberian materi yang berkaitan dengan
kompetensi yang diinginkan dalam blok MRP dengan cara ceramah dan diskusi di kelas.
Kuliah ini diharapkan dapat memberikan bekal kepada mahasiswa untuk menguasai konsep
dasar yang dibutuhkan dalam mencapai kompetensi yang telah ditetapkan. Kuliah diberikan
oleh dosen atau narasumber yang ahli dalam bidangnya. Pada kuliah ini, narasumber hanya
memberikan garis besar materi saja, pendalaman materi oleh mahaiswa dilakukan melalui
metode pembelajaran yang lain seperti praktikum dan belajar mandiri. Diharapkan dalam
memberikan kuliah dosen atau narasumber dapat memacu peran aktif mahasiswa.

1.B. TUTORIAL PENYUSUNAN PROPOSAL PENELITIAN

Mahasiswa dibagi menjadi kelompok-kelompok kecil dan didampingi oleh seorang
tutor. Tutor berperan sebagai pembimbing dalam penyusunan proposal penelitian yang
sudah ditulis oleh mahasiswa. Setiap mahasiswa wajib menulis bagian atau sub bab proposal
penelitian sesuai dengan jadwal yang sudah ditentukan. Pedoman penulisan proposal
penelitian mengacu pada Buku Panduan Skripsi dari Tim Skripsi FK Unsoed Jurusan
Kedokteran Umum tahun 2018. Tutorial merupakan waktu untuk mendapatkan bimbingan
dari tutor dan masukan dari teman sekelompoknya. Saat melakukan bimbingan, mahasiswa
mempresentasikan hasil tulisannya di depan tutor dan teman kelompoknya selama kurang
lebih 7 menit setiap mahasiswa. Mahasiswa memberikan hardcopy hasil tulisannya kepada
tutor saat bimbingan akan dimulai. Mahasiswa disarankan memiliki buku log untuk
mendokumentasikan setiap masukan atau hal-hal penting selama proses bimbingan
penulisan proposal penelitian. Proposal penelitian dikumpulkan kepada admin pada akhir
 9

blok sesuai waktu yang ditentukan oleh pengelola blok. Proposal penelitian dipresentasikan
pada jadwal SOCA di akhir blok dalam waktu 10 menit dengan ketentuan maksimal 10 slide
yang berisi Bab 1 dan Bab 3 dilanjutkan tanya jawab 5 menit.
 10

II. SKILLS/KETRAMPILAN
PRAKTIKUM PENGOLAHAN DATA
Praktikum pengolahan data merupakan praktikum yang dilakukan di laboratorium
komputer dengan tujuan agar mahasiswa dapat melakukan pengolahan data yang diperoleh pada
saat melakukan penelitian. Praktikum dipandu oleh staf dosen dan petugas laboratoium
komputer jurusan kedokteran FK Unsoed dan bersifat individual. Praktikum diselenggarakan
sebanyak 2 kali, masing-masing topik dibagi dalam dua gelombang. Praktikum pertama
mahasiswa berlatih mengolah data sebelum dianalisis. Praktikum kedua mahasiswa belajar
menganalis data hasil penelitian.
PRAKTIKUM ETIKA PENELITIAN
Praktikum Etika penelitian merupakan praktikum yang dilakukan di kelompok kecil
dengan tujuan agar mahasiswa dapat membuat dan mempraktikkan cara pengambilan informed
consent penelitian. Pada praktikum ini, mahasiswa membuat informed consent dan berpraktik
cara-cara pengambilan informed consent. Informed consent dibuat di rumah, kemudian
didiskusikan dan dipraktikkan dengan teman sekelompoknya, dengan dipandu oleh tutor.
PRAKTIKUM CRITICAL APPRAISAL
Praktikum critical appraisal merupakan praktikum yang dilakukan di kelompok kecil
dengan tujuan agar mahasiswa dapat menilai secara kritis kesahihan dan kemamputerapan
informasi jurnal. Setiap kelompok akan mendapatkan jurnal untuk dilakukan critical appraisal
menggunakan “CONSORT dan atau STROBE Statement”. Tiap kelompok melakukan critical
appraisal sebelum pelaksanaan praktikum dan dibahas pada saat praktikum bersama tutor.
EVALUASI PROSES PEMBELAJARAN

Evaluasi proses pembelajaran dilakukan oleh mahasiswa terhadap dosen, materi kuliah,
tutorial, praktikum dan ujian dalam bentuk kuesioner. Evaluasi diisi oleh setiap mahasiswa pada
akhir blok.

EVALUASI HASIL BELAJAR

Nilai akhir blok MRP ditentukan dengan kriteria sebagai berikut:

JENIS EVALUASI BOBOT NILAI

Ujian Tulis (CBT) 65%
Presentasi Proposal Penelitian 10%
Proposal Penelitian 25%
TOTAL 100%
 11

DAFTAR TUTOR
No Kelompok Nama
1 Kelompok 1 dr. Alfi Muntafiah, MSc.
2 Kelompok 2 Dr. dr. Dody Novrial, SpPA, MSi.Med.
3 Kelompok 3 dr. Dwi Arini Ernawati, MPH
4 Kelompok 4 Dr. dr. Dwi Utami Anjarwati, M.Kes.
5 Kelompok 5 dr. Fajar Wahyu Pribadi, MSc.
6 Kelompok 6 Dr. dr. Fitranto Arjadi, M.Kes.
7 Kelompok 7 dr. Gema Citra, MSi.Med
8 Kelompok 8 dr. Khusnul Muflikhah, MSc.
9 Kelompok 9 Dr. dr. Lantip Rujito, MSi.Med.
10 Kelompok 10 dr. Lieza Dwianasari S., M.Kes
11 Kelompok 11 dr. Vidya Dewantari, MH.
12 Kelompok 12 Dr. dr. Wahyu Siswandari, MSi.Med., SpPK.
 12

DAFTAR KELOMPOK

KELOMPOK 1 dr. Alfi Muntafiah, MSc. KELOMPOK 2 Dr. dr. Dody Novrial, SpPA, MSi.Med. KELOMPOK 3 dr. Dwi Arini Ernawati, MPH
NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA
1 G1A014021 RACHMA AMALIA KHANSA 1 G1A014052 R M RIZKY RADITYO 1 G1A014060 SAHRUL Z Z NUHUYANAN
2 G1A014034 AHMAD MUSTAFID ALWI 2 G1A014055 RAYNALDO ADNAN DINAR 2 G1A014072 LINTANG INGGAR SARI
3 G1A016001 AYUGITA NURAZIZAH TAMAD 3 G1A016003 MUHAMMAD 'UZAIR RIFA'I 3 G1A016005 NUR ZAFIKA
4 G1A016002 MOCH. IQBAL AFIF 4 G1A016004 FANI RUDIYANTI 4 G1A016006 DESSY OKTALIANA
5 G1A016026 NUR FITRIA ZAHRO 5 G1A016030 ANGGITA LARASATI PURBANINGRU 5 G1A016032 EPRILIA SEKARASIH PANENGAH
6 G1A016028 USWATUN KHASANAH 6 G1A016031 ASPIANNUR 6 G1A016033 HAWARIYYUN SASTRANEGARA
7 G1A016053 NINA VANESSA WIHARTONO 7 G1A016055 MUHAMMAD HASHFI LUTHFILLAH H 7 G1A016057 NADZIFA NURAMDANI FATHONY
8 G1A016054 ANANDA ANGGI AMELIA M 8 G1A016056 ABDUL AZIZ ASYHARI 8 G1A016058 ALIFAH NURUL ISLAM
9 G1A016079 MAHENDRA AULIA RAKHMAN 9 G1A016081 IMELIA ANGGRAENI 9 G1A016083 FANIA SALSABILLA MAHATMA P
10 G1A016080 ABDURRAHMAN QANITURRAZAN 10 G1A016082 FARHANA SAMAD 10 G1A016084 JEREMY FERNANDO CLINTON
11 G1A016104 ZUNAIRI NUR ARIFAH 11 G1A016106 ULYA JIHAN MUNA 11 G1A016108 NUR MUHAMMAD MUMTAZ WAHYU

KELOMPOK 4 Dr.dr.Dwi Utami Anjarwati,M.Kes. KELOMPOK 5 dr. Fajar Wahyu Pribadi, MSc. KELOMPOK 6 Dr. dr. Fitranto Arjadi, M.Kes.
NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA
1 G1A014074 SHAFIRA ZAKI AMIRA 1 G1A014087 DYAH AYU ANASTASYA P 1 G1A014089 FAUZAN HAKIM
2 G1A014085 MEGA RANI ANGGERENI 2 G1A014088 RIO KURNIA GULTOM 2 G1A014090 DOMAS SHIFA YUDI A
3 G1A016007 DESTIA NUR MILENIA.S 3 G1A016010 MUHAMMAD RIFQI FAUZAN N 3 G1A016012 MAHARANI KARTIKA DEWI
4 G1A016009 SELMI JUNITA RAHMAWATI 4 G1A016011 DWIASTINI AYU WARDHANA TALLU 4 G1A016013 SILVYMAY NURBASUKI
5 G1A016034 NABILA SULISTYAWATI 5 G1A016036 RIZKI AGUNG NUGRAHA 5 G1A016038 FIQHAM MUHAMAD PUTRA
6 G1A016035 ZEVIC AULIA NOOR 6 G1A016037 CAYLA VIESTANIA SALSABILLA 6 G1A016039 MASITA ROCHSALEHA M. GANI
7 G1A016059 KARENIA PRAPTININGTYAS 7 G1A016061 PRAMESA JUAN FADILAH 7 G1A016063 ALIFIA WENI BHAMATIKA
8 G1A016060 FITRI PANGESTUTI 8 G1A016062 DIAS RUDI HARYADI 8 G1A016065 YAHYA KHAIRYHANIF
9 G1A016085 WELLEN DEXIA BINTORO 9 G1A016088 FIRDA SOFIANA ZAHRA 9 G1A016090 YULGEA DELLA AMALIA
ANGGIRIANI RAHMAWATI
10 G1A016087 LARASATI 10 G1A016089 RATRI PRABAHANINDYA 10 G1A016091 TALIA ISLAMI
11 G1A016110 IMAM AGUS FAISAL 11 G1A016111 SALMA NUR AMALIA 11 G1A016112 AISYAH PUTERI HUTAMI
 13

KELOMPOK 7 dr. Gema Citra, MSi.Med KELOMPOK 8 dr. Khusnul Muflikhah, MSc. KELOMPOK 9 Dr. dr. Lantip Rujito, MSi.Med.
NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA
1 G1A014092 RIZKY BAYU LESMANA 1 G1A014093 PRISILIA A A KALALO 1 G1A014097 MOH. AZWAR ANSORI
2 G1A016014 MARHAMDANI 2 G1A016016 RANIA NISRINA ALIFAH 2 G1A016018 RATIH BAHARI
3 G1A016015 AVIASENNA ANDRIAND 3 G1A016017 DAMAR PANDURIZKY 3 G1A016019 AHMAD WAHYU PAMUNGKAS
4 G1A016040 MUHAMMAD RIDWANSYAH 4 G1A016043 MAULITA ZULFIANI 4 G1A016045 GISMA CHAIRUN NISA
5 G1A016042 MAHAYU DIAN SURYANDARU 5 G1A016044 MOCH RIZKYA NIDI RAMADHAN 5 G1A016046 PADANG DWIKA APRILIAN
6 G1A016066 NUDAR FATAHA 6 G1A016069 DEWI ITIKA BASUKI 6 G1A016071 TSANIA EL IZZ AVINDA
7 G1A016067 ASHA HANIAZIZA 7 G1A016070 ADITYA EKA OCTAVIAN 7 G1A016072 FADHLY NINO PUTRA
8 G1A016092 FRIDHA PUTRI RISTIANAWATI 8 G1A016094 VANIA PUJI LESTARI 8 G1A016096 BIMAHFUD INDRANATA
9 G1A016093 ENDAH RAMADHATININGSIH 9 G1A016095 FADHILAH YUDHISTIA TARUNA 9 G1A016097 KRESNA MUKTI
10 G1A016113 MUHAMMAD AL ROFI INTERNA D 10 G1A016115 RADEN ALVIN RENALDI NATASASMITA 10 G1A016117 CINDY LORENZA DARWIS
11 G1A016114 APRILIA GISKA DEVIEANTY 11 G1A016116 DEUIS GUSTIANI RAHAYU 11 G1A016118 RADITYA IRFAN PRADHANA

KELOMPOK 10 dr. Lieza Dwianasari S., M.Kes KELOMPOK 11 dr. Vidya Dewantari, MH. KELOMPOK 12 dr. Vidya Dewantari, MH.
NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA
1 G1A014105 AVLYA ZELYKA AZ ZAHRA 1 G1A014108 FIQROTUL UMAM 1 G1A014113 AHMAD ZULFIKAR
2 G1A016020 RIA WULANDARI SUDARTO 2 G1A016022 NABILAH HANNA PUSPADEWI 2 G1A016024 BALQIS AMATULLOH
3 G1A016021 DWI LILIYANI 3 G1A016023 NUR AMALIA RACHMAWATI 3 G1A016025 QONITA
4 G1A016047 JARWATI 4 G1A016049 MUHAMMAD IQBAL FIRDAUS 4 G1A016051 CITRA KHARISMA ZULFA
5 G1A016048 AHMAD MUSAFI HAZAN 5 G1A016050 ARYA INDRA MADANI 5 G1A016052 GUSTI RAMA DWITIYA
6 G1A016073 DHIESTY KUSUMA PURBASARI 6 G1A016075 REFIN WAHYUBASKORO 6 G1A016077 TRI RAMDANI
7 G1A016074 ADI PUTRA WIJAYA 7 G1A016076 ARIESTA RIENDRIAS 7 G1A016078 DHIO ARIEYONA
8 G1A016098 RIZA DWI UTAMI 8 G1A016100 AULIA QUROTA AYUN 8 G1A016102 FARHAN CAHAYA PRIMADANI
9 G1A016099 ELSYRA NUR RAHMAT 9 G1A016101 INDRIANI TANTI KARTINI 9 G1A016103 DEWI PRAMESTI NUR AISYAH
10 G1A016105 DELIMA ROCHMAH NUR SYAHBANI 10 G1A016107 AMALIA ALMAS 10 G1A016109 DEWI EMALA KARTIKA
11 G1A016119 VANNY PRANANDA 11 G1A016120 RIZKY PRATAMA SANTOSO 11
 14

JADWAL BLOK 5.2 TA. 2018/2019

WAKTU Senin Selasa Rabu Kamis Jumat
24 September 2018 25 September 2018 26 September 2018 27 September 2018 28 September 2018
07.00-07.50
10.Instrumen penelitian
Sosialisasi Pembelajaran 3. Variabel dan Skala kualitatif (Diyah
08.00-08.50 6.Dasar-dasar Biostatistika 8.Sampling dan Estimasi (dr. Woro,S.Psi.M.Psi)
Penelitian (DR.dr Lantip Rujito,
(dr. Yudhi Wibowo, M.PH) Yudhi Wibowo, M.PH)
1.Hipotesis Penelitian (dr. Msi.Med)
09.00-09.50 Yudhi Wibowo, M.PH) 11.Pengolahan dan Penyajian
2.Populasi dan Sampel (dr. Data Kualitatif (Diyah Woro)
4.Pengukuran Data dan
10.00-10.50 Yudhi Wibowo, M.PH) 7.Statistik Deskriptif (Dr.dr.
Instrumen Penelitian (Dr.dr. TUTORIAL 1
Nendyah Roestijawati, MKK)
11.00-11.50 Nendyah Roestijawati, MKK)
Istirahat
12.00-12.50 Istirahat Istirahat Istirahat Istirahat
5.Teknik Penulisan Proposal 9.Rancangan Penelitian
13.00-13.50 Penelitian, Laporan Penelitian, Jurnal
Ilmiah, dan Poster Ilmiah (dr. Vitasari
Skills Lab Kualitatif (dr. Miko Ferine,
Indriyani, Sp.PK,MM.,Msi.Med) M.Med.Ed)
14.00-14.50

WAKTU Senin Selasa Rabu Kamis Jumat

1 Oktober 2018 2 Oktober 2018 3 Oktober 2018 4 Oktober 2018 5 Oktober 2018
07.00-07.50
14.Rancangan Penelitian
08.00-08.50 12.Rancangan Penelitian 18.Statisik Parametrik dan
Eksperimental Laboratoris 16.Pengolahan Data (Dr.dr. 19.Uji Beda Pada 2 Kelompok
Kuantitatif (Dr.dr. Eman Non Parametrik (Dr.dr.
(Dr.dr.Dody Novrial, SpPA., Lantip Rujito, M.Si. Med) (Khusnul Muflikhah, M.Sc)
Sutrisna., M.Kes) Nendyah Roestijawati, MKK)
09.00-09.50 M.Si.Med)
13.Penelitian Epidemiologi 20.Uji Beda Antara 3
10.00-10.50 17.Uji Hipotesis (dr. Yudhi
Observasional (Dr.dr.Nendyah TUTORIAL 2 TUTORIAL 3 Kelompok atau Lebih (dr. Alfi
Roestijawati,MKK)
Wibowo, M.PH)
11.00-11.50 Muntafiah, M.Sc )
12.00-12.50 Istirahat Istirahat Istirahat Istirahat Istirahat
15.Rancangan Penelitian
13.00-13.50 Eksperimental Dengan Subyek
Skills Lab
Manusia (Dr.dr. Wahyu
14.00-14.50 Siswandari, Sp.PK., M.Si.Med)
 15

WAKTU Senin Selasa Rabu Kamis Jumat

8 Oktober 2018 9 Oktober 2018 10 Oktober 2018 11 Oktober 2018 12 Oktober 2018
07.00-07.50
27.Telaah Jurnal Ilmiah dan
08.00-08.50 21.Analisis Multivariabel (dr. 23.Uji Korelasi (dr. Yudhi 25.Etika Penelitian (dr. Miko
Critical Appraisal Dr.dr.
Yudhi Wibowo, M.PH) Wibowo, M.PH) Ferine, M.Med.Ed)
09.00-09.50 Nendyah Roestijawati, MKK )
CBT I (1-14)
10.00-10.50 24.Uji Asosiasi (dr. Yudhi Praktikum Etika Penelitian
TUTORIAL 4 TUTORIAL 5
Wibowo, M.PH) (Kelompok kecil) (di R.PBL)
11.00-11.50
12.00-12.50 Istirahat Istirahat Istirahat Istirahat Istirahat
13.00-13.50 22.Uji Regresi (dr. Yudhi 26.Analisis Kualitatif (RR.Dyah Praktikum Pengolahan Data 1
Skills Lab
14.00-14.50 Wibowo, M.PH) Woro, M.A) Gelombang I

WAKTU Senin Selasa Rabu Kamis Jumat

15 Oktober 2018 16 Oktober 2018 17 Oktober 2018 18 Oktober 2018 19 Oktober 2018
07.00-07.50

08.00-08.50 Praktikum Pengolahan Data Praktikum Pengolahan Data 2

1 Gelombang II Gelombang II
09.00-09.50
CBT II (15-27) REMIDI CBT
10.00-10.50 Praktikum Pengolahan Data Praktikum Critical Appraisal 2
Presentasi Proposal
2 Gelombang I (kelompok kecil) (di R.PBL)
11.00-11.50
12.00-12.50 Istirahat Istirahat Istirahat Istirahat Istirahat
Praktikum Critical Appraisal
13.00-13.50 1 (kelompok kecil) (di Skills Lab
R.PBL)
14.00-14.50
 16

TEKNIS PELAKSANAAN KEGIATAN

1. KULIAH
- Kuliah dilaksanakan di ruang kuliah gedung A
- Admin blok mengingatkan dosen pengampu sehari sebelum perkuliahan.
- Mahasiswa datang 10 menit sebelum perkuliahan dimulai.
- Mahasiswa bersama caraka mengecek sound system dan LCD sebelum dosen datang
- Tiga puluh menit dosen tidak datang tanpa pemberitahuan, kuliah dianggap batal dan digantikan pada
jadwal yang lain.
2. TUTORIAL PENYUSUNAN PROPOSAL PENELITIAN
- Tutorial penyusunan proposal penelitian dilaksanakan di ruang PBL sesuai jadwal yang sudah
ditentukan.
- Mahasiswa perwakilan kelompok mengingatkan tutor sehari sebelum jadwal tutorial.
- Mahasiswa menyusun dan menulis proposal penelitian untuk dikonsultasikan dan dipresentasikan
pada saat tutorial. Ketentuan penyusunan proposal penelitian mengacu pada Buku Petunjuk
Penulisan Skripsi 2018, dengan pembagian:
 Tutorial 1 :BAB I (Latar Belakang, Perumusan Masalah, Tujuan dan Manfaat, Keaslian Penelitian)
 Tutorial 2 :BAB II (Materi Pustaka, Kerangka Pemikiran Penelitian, Kerangka Konsep Penelitian,
Hipotesis)
 Tutorial 3 :BAB III
o Penelitian Observasional (epidemiologis): Rancangan Penelitian, Populasi dan Sampel,
Variabel Penelitian, Definisi Operasional Variabel
o Penelitian Eksperimental Laboratorium:Rancangan Penelitian, Rancangan Percobaan dan
Pengambilan Sampel, Materi dan Bahan, Variabel yang diukur
 Tutorial 4 : BAB III
o Penelitian Observasional (epidemiologis): (Pengumpulan Data, Tata Urutan Kerja, Analisis
Data, Waktu dan Tempat Penelitian, Jadwal Penelitian)
o Penelitian Eksperimental Laboratorium: Cara Mengukur variabel, Tata urutan Kerja, Analisis
Data, Waktu dan Tempat, Jadwal Penelitian.
 Tutorial 5 : Review BAB I-BABIII
 Tugas mahasiswa:
o Menulis proposal penelitian sesuai ketentuan jadwal pertemuan tutorial.
o Menyerahkan hardcopy proposal penelitian yang sudah ditulis sesuai jadwal pertemuan
tutorial.
o Mempresentasikan proposal penelitian dalam bentuk power point selama maksimal 7
menit.
o Merevisi proposal penelitian sesuai masukan tutor dan teman kelompok.
 17

o Di akhir tutorial ke-3 dan ke-4 mahasiswa diminta membuat satu resume mengenai desain
penelitian satu teman sekelompoknya (yang berbeda dengan desainnya). Format resume
bebas, ditulis tangan, dikumpulkan ke sekretariat blok maksimal 24 jam setelah selesai
tutorial.
o Memberi masukan terhadap proposal penelitian teman kelompoknya.
 Tugas tutor:
o Mendengarkan dan mencermati pemaparan proposal penelitian oleh setiap mahasiswa.
o Memberikan arahan, koreksi, dan masukan terhadap proposal penelitian yang telah dibuat
oleh mahasiswa.
3. PRAKTIKUM PENGOLAHAN DATA
- Praktikum dilaksanakan di Laboratorium Komputer.
- Praktikum dilaksanakan 2 kali, masing-masing 2 gelombang.
a. Praktikum 1 : Pengolahan data
b. Praktikum 2 : Analisis data
- Mahasiswa membaca referensi praktikum : Pengantar Statistika Kedokteran (M.Sopiyudin Dahlan)
4. PRAKTIKUM INFORMED CONSENT
Praktikum ini dilaksanakan satu kali. Mahasiswa membuat informed consent sesuai topik penelitiannya
di rumah, kemudian di review bersama dengan teman sekelompok dan sekaligus dipraktekkan pada saat
praktikum, dipandu oleh tutor).
- Tugas mahasiswa:
o Membuat informed consent di rumah
o Mereview dan mendiskusikan informed consent dengan tutor dan teman kelompoknya
(berpasangan)
o Berpraktik cara menyampaikan informed consent kepada orang awam pada saat praktikum
(berpasangan).
- Tugas tutor:
o Memberi masukan terhadap informed consent yang dibuat oleh mahasiswa.
o Memberi masukan terhadap praktik mahasiswa dalam menyampaikan informed consent
kepada orang awam.
5. PRAKTIKUM CRITICAL APPRAISAL
- Praktikum dilaksanakan di ruang PBL
- Praktikum dipandu oleh seorang tutor.
- Mahasiswa mengerjakan appraisal sebelum praktikum dilaksanakan dan dikumpulkan serta dibahas
pada saat praktikum.
- Pada praktikum critical appraisal 1, dilakukan menggunakan STROBE statement terhadap jurnal yang
sudah ditentukan.
- Praktikum critical appraisal 2, dilakukan menggunakan CONSORT statement terhadap jurnal yang sudah
ditentukan.
 18

- Tugas Mahasiswa:
o Masing-masing mahasiswa melakukan critical appraisal di rumah.
o Mencetak dan membawanya saat praktikum.
o Mendiskusikan dengan tutor dan teman kelompoknya.
- Tugas Tutor:
o Membahas dan mendiskusikan critical appraisal bersama mahasiswa terhadap jurnal yang
sudah disediakan.

Praktikum Critical Appraisal 1

Kelompok 1 & 7 Socio-demographic factors affecting the choice of place of childbirth
among migrant and native women – A case control study from
Chandigarh, India
Kelompok 2 & 8 Aging, Obesity, and the Incidence of Diverticulitis: A Population-Based
Study
Kelompok 3 & 9 Family socioeconomic status and maternal depressive symptoms:
Mediation through household food insecurity across five years☆
Kelompok 4 & 10 Survival status of hiv positive adults on antiretroviral treatment in Debre
Markos Referral Hospital, Northwest Ethiopia: retrospective cohort
study
Kelompok 5 & 11 Multiple Sclerosis and Related Disorders Low Vitamin D-25(OH)
Level in Indonesian Multiple Sclerosis and Neuromyelitis Optic
Patients
Kelompok 6 & 12 Motivators, barriers and strategies of weight management: A cross-
sectional study among Finnish adults

Praktikum Critical Appraisal 2

Kelompok 1-3 Evaluation of the gastrointestinal tract in mdx mice: an experimental
model of Duchenne muscular dystrophy
Kelompok 4-6 Antioxidant and anti-inflammatory activities of Berberine attenuate
hepatic fibrosis induced by thioacetamide injection in rats
Kelompok 7-9 The Natural Rotenoid Deguelin Ameliorates Diabetic Neuropathy by
Decreasing Oxidative Stress and Plasma Glucose Levels in Rats via
the Nrf2 Signalling Pathway
Kelompok 10-12 Attenuation of oxidative stress and cardioprotective effects of zinc
supplementation in experimental diabetic rats

6. Ujian Tulis Komprehensif

- Ujian tulis komprehensif (UTK) dilaksanakan sesuai jadwal yang telah ditetapkan.
 19

- Bentuk soal UTK adalah Multiple Choice Question dengan satu pilihan jawaban benar yang
dilaksanakan dengan Computer Based Test.
7. Presentasi Proposal Penelitian
- Presentasi proposal penelitian dilaksanakan di ruang PBL.
- Setiap mahasiswa membuat presentasi dalam bentuk power point maksimal 10 slide yang berisi Bab
1-3.
- Waktu presentasi adalah 7 menit dan tanya jawab 5 menit.
- Mahasiswa dipanggil satu-persatu untuk presentasi.
- Mahasiswa yang tidak sedang presentasi berada di ruang karantina.
- Penilaian oleh seorang penguji meliputi sikap, penyajian, kemampuan mengemukakan pendapat,
penguasaan materi.
8. Naskah Proposal Penelitian
- Naskah proposal penelitian diserahkan admin blok pada hari Senin, 15 Oktober 2018 maksimal pukul
10.00.
- Naskah proposal penelitian akan diberikan kepada penguji 2 hari sebelum presentasi proposal
penelitian.
- Penguji memberikan penilaian terhadap proposal penelitian dan lembar hasil penilaian diserahkan
kepada admin blok paling lambat setelah presentasi proposal penelitian.
- Penilaian naskah proposal penelitian sesuai dengan ketentuan Buku Panduan Penulisan Skripsi Tahun
2018.

LAMPIRAN
1. Daftar STROBE dan CONSORT
2. Buku Panduan Penulisan SKRIPSI 2018
3. Daftar jurnal untuk critical appraisal
4. Peraturan Akademik 2018
 20

STROBE Statement—Checklist of items that should be included in reports of cross-sectional studies

Item
No Recommendation
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract
(b) Provide in the abstract an informative and balanced summary of what was done
and what was found
Introduction
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported
Objectives 3 State specific objectives, including any prespecified hypotheses
Methods
Study design 4 Present key elements of study design early in the paper
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment,
exposure, follow-up, and data collection
Participants 6 (a) Give the eligibility criteria, and the sources and methods of selection of
participants
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect
modifiers. Give diagnostic criteria, if applicable
Data sources/ 8* For each variable of interest, give sources of data and details of methods of
measurement assessment (measurement). Describe comparability of assessment methods if there is
more than one group
Bias 9 Describe any efforts to address potential sources of bias
Study size 10 Explain how the study size was arrived at
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable,
describe which groupings were chosen and why
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding
(b) Describe any methods used to examine subgroups and interactions
(c) Explain how missing data were addressed
(d) If applicable, describe analytical methods taking account of sampling strategy
(e) Describe any sensitivity analyses
Results
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially
eligible, examined for eligibility, confirmed eligible, included in the study,
completing follow-up, and analysed
(b) Give reasons for non-participation at each stage
(c) Consider use of a flow diagram
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and
information on exposures and potential confounders
(b) Indicate number of participants with missing data for each variable of interest
Outcome data 15* Report numbers of outcome events or summary measures
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and
their precision (eg, 95% confidence interval). Make clear which confounders were
adjusted for and why they were included
(b) Report category boundaries when continuous variables were categorized
(c) If relevant, consider translating estimates of relative risk into absolute risk for a
meaningful time period
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and
sensitivity analyses
 21

Discussion
Key results 18 Summarise key results with reference to study objectives
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or
imprecision. Discuss both direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations,
multiplicity of analyses, results from similar studies, and other relevant evidence
Generalisability 21 Discuss the generalisability (external validity) of the study results
Other information
Funding 22 Give the source of funding and the role of the funders for the present study and, if
applicable, for the original study on which the present article is based

*Give information separately for exposed and unexposed groups.

Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and
published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely
available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at
http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is
available at www.strobe-statement.org.
 22

STROBE Statement—Checklist of items that should be included in reports of cohort studies

Item
No Recommendation
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract
(b) Provide in the abstract an informative and balanced summary of what was done
and what was found
Introduction
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported
Objectives 3 State specific objectives, including any prespecified hypotheses
Methods
Study design 4 Present key elements of study design early in the paper
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment,
exposure, follow-up, and data collection
Participants 6 (a) Give the eligibility criteria, and the sources and methods of selection of
participants. Describe methods of follow-up
(b) For matched studies, give matching criteria and number of exposed and
unexposed
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect
modifiers. Give diagnostic criteria, if applicable
Data sources/ 8* For each variable of interest, give sources of data and details of methods of
measurement assessment (measurement). Describe comparability of assessment methods if there is
more than one group
Bias 9 Describe any efforts to address potential sources of bias
Study size 10 Explain how the study size was arrived at
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable,
describe which groupings were chosen and why
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding
(b) Describe any methods used to examine subgroups and interactions
(c) Explain how missing data were addressed
(d) If applicable, explain how loss to follow-up was addressed
(e) Describe any sensitivity analyses
Results
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially
eligible, examined for eligibility, confirmed eligible, included in the study,
completing follow-up, and analysed
(b) Give reasons for non-participation at each stage
(c) Consider use of a flow diagram
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and
information on exposures and potential confounders
(b) Indicate number of participants with missing data for each variable of interest
(c) Summarise follow-up time (eg, average and total amount)
Outcome data 15* Report numbers of outcome events or summary measures over time
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and
their precision (eg, 95% confidence interval). Make clear which confounders were
adjusted for and why they were included
(b) Report category boundaries when continuous variables were categorized
(c) If relevant, consider translating estimates of relative risk into absolute risk for a
meaningful time period
2
3

1
 24

Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and
sensitivity analyses
Discussion
Key results 18 Summarise key results with reference to study objectives
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or
imprecision. Discuss both direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations,
multiplicity of analyses, results from similar studies, and other relevant evidence
Generalisability 21 Discuss the generalisability (external validity) of the study results
Other information
Funding 22 Give the source of funding and the role of the funders for the present study and, if
applicable, for the original study on which the present article is based

*Give information separately for exposed and unexposed groups.

Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and
published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely
available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at
http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is
available at http://www.strobe-statement.org.
 25

STROBE Statement—Checklist of items that should be included in reports of case-control studies

Item
No Recommendation
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract
(b) Provide in the abstract an informative and balanced summary of what was done
and what was found
Introduction
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported
Objectives 3 State specific objectives, including any prespecified hypotheses
Methods
Study design 4 Present key elements of study design early in the paper
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment,
exposure, follow-up, and data collection
Participants 6 (a) Give the eligibility criteria, and the sources and methods of case ascertainment
and control selection. Give the rationale for the choice of cases and controls
(b) For matched studies, give matching criteria and the number of controls per case
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect
modifiers. Give diagnostic criteria, if applicable
Data sources/ 8* For each variable of interest, give sources of data and details of methods of
measurement assessment (measurement). Describe comparability of assessment methods if there is
more than one group
Bias 9 Describe any efforts to address potential sources of bias
Study size 10 Explain how the study size was arrived at
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable,
describe which groupings were chosen and why
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding
(b) Describe any methods used to examine subgroups and interactions
(c) Explain how missing data were addressed
(d) If applicable, explain how matching of cases and controls was addressed
(e) Describe any sensitivity analyses
Results
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially
eligible, examined for eligibility, confirmed eligible, included in the study,
completing follow-up, and analysed
(b) Give reasons for non-participation at each stage
(c) Consider use of a flow diagram
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and
information on exposures and potential confounders
(b) Indicate number of participants with missing data for each variable of interest
Outcome data 15* Report numbers in each exposure category, or summary measures of exposure
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and
their precision (eg, 95% confidence interval). Make clear which confounders were
adjusted for and why they were included
(b) Report category boundaries when continuous variables were categorized
(c) If relevant, consider translating estimates of relative risk into absolute risk for a
meaningful time period
 26

Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses

Discussion
Key results 18 Summarise key results with reference to study objectives
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision.
Discuss both direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity
of analyses, results from similar studies, and other relevant evidence
Generalisability 21 Discuss the generalisability (external validity) of the study results
Other information
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable,
for the original study on which the present article is based

*Give information separately for cases and controls.

Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and
published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely
available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at
http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available
at http://www.strobe-statement.org.
 27

STROBE Statement—checklist of items that should be included in reports of observational studies

Item Page Relevant text from

No. Recommendation No. manuscript
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract
(b) Provide in the abstract an informative and balanced summary of what was done and what was
found
Introduction
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported
Objectives 3 State specific objectives, including any prespecified hypotheses
Methods
Study design 4 Present key elements of study design early in the paper
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure,
follow-up, and data collection
Participants 6 (a) Cohort study—Give the eligibility criteria, and the sources and methods of selection of
participants. Describe methods of follow-up
Case-control study—Give the eligibility criteria, and the sources and methods of case
ascertainment and control selection. Give the rationale for the choice of cases and controls
Cross-sectional study—Give the eligibility criteria, and the sources and methods of selection of
participants
(b) Cohort study—For matched studies, give matching criteria and number of exposed and
unexposed
Case-control study—For matched studies, give matching criteria and the number of controls per
case
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers.
Give diagnostic criteria, if applicable
Data sources/ 8* For each variable of interest, give sources of data and details of methods of assessment
measurement (measurement). Describe comparability of assessment methods if there is more than one group
Bias 9 Describe any efforts to address potential sources of bias
Study size 10 Explain how the study size was arrived at
Continued on next page

1
 28

Quantitative 11 Explain how quantitative variables were handled in the analyses. If applicable, describe which
variables groupings were chosen and why
Statistical 12 (a) Describe all statistical methods, including those used to control for confounding
methods (b) Describe any methods used to examine subgroups and interactions
(c) Explain how missing data were addressed
(d) Cohort study—If applicable, explain how loss to follow-up was addressed
Case-control study—If applicable, explain how matching of cases and controls was addressed
Cross-sectional study—If applicable, describe analytical methods taking account of sampling
strategy
(e) Describe any sensitivity analyses
Results
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined
for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed
(b) Give reasons for non-participation at each stage
(c) Consider use of a flow diagram
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and information on
exposures and potential confounders
(b) Indicate number of participants with missing data for each variable of interest
(c) Cohort study—Summarise follow-up time (eg, average and total amount)
Outcome data 15* Cohort study—Report numbers of outcome events or summary measures over time
Case-control study—Report numbers in each exposure category, or summary measures of exposure
Cross-sectional study—Report numbers of outcome events or summary measures
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision
(eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were
included
(b) Report category boundaries when continuous variables were categorized
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time
period
Continued on next page

2
 29

Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses
Discussion
Key results 18 Summarise key results with reference to study objectives
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss
both direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of
analyses, results from similar studies, and other relevant evidence
Generalisability 21 Discuss the generalisability (external validity) of the study results
Other information
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the
original study on which the present article is based

*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.

Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The
STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine
at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org.
 30

CONSORT 2010 checklist of information to include when reporting a randomised trial *

Item Reported
Section/Topic No Checklist item on page No
Title and abstract
1a Identification as a randomised trial in the title
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts)
Introduction
Background and 2a Scientific background and explanation of rationale
objectives 2b Specific objectives or hypotheses

Methods
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons
Participants 4a Eligibility criteria for participants
4b Settings and locations where the data were collected
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were
actually administered
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they
were assessed
6b Any changes to trial outcomes after the trial commenced, with reasons
Sample size 7a How sample size was determined
7b When applicable, explanation of any interim analyses and stopping guidelines
Randomisation:
Sequence 8a Method used to generate the random allocation sequence
generation 8b Type of randomisation; details of any restriction (such as blocking and block size)
Allocation 9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers),
concealment describing any steps taken to conceal the sequence until interventions were assigned
mechanism
Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to
interventions
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those

CONSORT 2010 checklist Page 1

 31

assessing outcomes) and how

11b If relevant, description of the similarity of interventions
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses
Results
Participant flow (a 13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and
diagram is strongly were analysed for the primary outcome
recommended) 13b For each group, losses and exclusions after randomisation, together with reasons
Recruitment 14a Dates defining the periods of recruitment and follow-up
14b Why the trial ended or was stopped
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was
by original assigned groups
Outcomes and 17a For each primary and secondary outcome, results for each group, and the estimated effect size and its
estimation precision (such as 95% confidence interval)
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing
pre-specified from exploratory
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms)
Discussion
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses
Generalisability 21 Generalisability (external validity, applicability) of the trial findings
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence
Other information
Registration 23 Registration number and name of trial registry
Protocol 24 Where the full trial protocol can be accessed, if available
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders

*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If relevant, we also
recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic
trials. Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org.

CONSORT 2010 checkli

 32

Lampiran 16. Formulir penilaian seminar usul skripsi (form-09a)

FORM-09a

KEMENTERIAN RISET, TEKNOLOGI, DAN PENDIDIKAN TINGGI

UNIVERSITAS JENDERAL SOEDIRMAN
FAKULTAS KEDOKTERAN
Jalan Dr. Gumbreg Nomor 1 Berkoh Purwokerto 53146 Telepon (0281) 622022
Laman: http://fk.unsoed.ac.id E-mail: psi.fk@unsoed.ac.id

DAFTAR NILAI SEMINAR USUL SKRIPSI

Nama : __________________________________________________
NIM : __________________________________________________
Semester : __________________________________________________

Nilai
No Mata Uji / Penilaian Keterangan
Angka Huruf
1 Sikap
2 Penyajian
Kemampuan Mengemukakan
3
Pendapat
4 Penguasaan Materi
Jumlah
Rata - Rata

Purwokerto, __________________
Dosen Penilai,

________________________
NIP.
Nilai :
A = > 80
B = 66 – 79.9
C = 56 – 65.9
 33

D = < 46
Lampiran 18. Formulir penilaian usul skripsi (Form-11)
FORM-11
LEMBAR PENILAIAN USUL SKRIPSI
JURUSAN KEDOKTERAN
FAKULTAS KEDOKTERAN
UNIVERSITAS JENDERAL SOEDIRMAN

Nama :
NIM :
JUDUL :
PEMBIMBING I :
PEMBIMBING II :
PENGUJI :

No Topik Bobot Nilai Bobot

x Nilai
1 Judul 10% 0-100
Mencerminkan isi/ masalah penelitian dengan jelas dan
menggunakan kalimat lengkap, efektif/ padat sesuai kaidah
Bahasa Indonesia yang baik dan benar
2 Pendahuluan 30% 0-100
Didasari dari latar belakang secara umum menuju ke suatu
pertanyaan penelitian atau hipotesis dan disusun berdasarkan
fakta-fakta dan informasi yang mendorong atau alasan
pentingnya dilakukan penelitian yang disusun secara
sistematis, logis dan ringkas.
Tujuan dan manfaat penelitian diuraikan secara jelas dan
nyata dan relevansinya dengan masalah yang hendak
dipecahkan
3 Tinjauan Pustaka 30% 0-100
Kerangka teori dan kerangka konsep
Referensi relevan sebagai dasar menjawab sementara sumber
permasalahan
Sumber pustaka minimal 50% berupa jurnal dilengkapi
dengan buku teks, kamus, dll
Hipotesis dirumuskan secara sederhana, jelas, padat, dapat
diuji dan dinyatakan dalam kalimat deklaratif
4 Metode Penelitian 30% 0-100
Materi dan Bahan (populasi dan sampel) : Sasaran/ materi dan
bahan yang akan digunakan dalam penelitian, termasuk
metode pengambilan sampel untuk penelitian non
eksperimental
Ketepatan metode penelitian yang digunakan (eksperimental
atau non eksperimental), dijabarkan secara rinci termasuk
langkah-langkah penelitian
 34

Batasan operasional variable yang diukur dijelaskan secara

tegas serta alat dan cara pengukurannya (validitas dan
reliabilitasnya)
Metode statistik yang digunakan untuk analisis data sesuai
dengan rancangan penelitiannya
TOTAL
Purwokerto………………
Penguji,

(…………………………….)

NIP………………………….